Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-01 Sale |
2023-08-03 07:09 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" |
52,742 | $8.2987 | $437,690 | 158,228 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:05 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
65,966 | $9.5536 | $630,216 | 2,974 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:04 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
6,265 | $9.5536 | $59,853 | 173,262 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:03 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
77,421 | $9.5536 | $739,653 | 165,381 (Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:02 pm |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
72,009 | $9.5536 | $687,949 | 69,770 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 07:38 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
63,383 | $9.8866 | $626,642 | 21,404 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 07:34 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
33,685 | $9.8866 | $333,030 | 131,014 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 07:33 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
59,655 | $9.8866 | $589,785 | 182,727 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 07:33 am |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
44,252 | $9.8866 | $437,502 | 90,369 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-01 Exercise |
2023-08-03 07:09 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" |
52,742 | $0 | 158,228 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 07:39 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Zaks Tal Zvi Director |
21,108 | $0 | 21,108 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 07:38 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Vergis Janet S. Director |
21,108 | $0 | 21,108 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 07:37 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Satchi-Fainaro Ronit Director |
21,108 | $0 | 21,108 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 07:36 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Nisen Perry Director |
21,108 | $0 | 21,108 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 07:35 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director |
21,108 | $0 | 21,108 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 07:34 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | LIEBERMAN GERALD M Director |
21,108 | $0 | 21,108 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 07:33 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Elstein Amir Director |
21,108 | $0 | 21,108 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 07:32 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Crane Rosemary A Director |
21,108 | $0 | 21,108 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 07:31 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | BARER SOL J Director |
37,598 | $0 | 37,598 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:15 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
20,717 | $0 | 101,082 (Direct) |
View |
| 2023-03-04 Exercise |
2023-03-07 4:15 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
16,646 | $0 | 101,082 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:14 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
94,621 | $0 | 299,470 (Direct) |
View |
| 2023-03-04 Exercise |
2023-03-07 4:14 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
65,966 | $0 | 299,470 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli EVP,Global Marketing&Portfolio |
59,760 | $0 | 186,103 (Direct) |
View |
| 2023-03-04 Exercise |
2023-03-07 4:13 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli EVP,Global Marketing&Portfolio |
29,176 | $0 | 186,103 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
99,601 | $0 | 569,348 (Direct) |
View |
| 2023-03-04 Exercise |
2023-03-07 4:11 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
73,197 | $0 | 569,348 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
199,202 | $0 | 476,802 (Direct) |
View |
| 2023-03-04 Exercise |
2023-03-07 4:10 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
54,899 | $0 | 476,802 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Inbar Galia See "Remarks" |
59,760 | $0 | 177,514 (Direct) |
View |
| 2023-03-04 Exercise |
2023-03-07 4:08 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Inbar Galia See "Remarks" |
25,817 | $0 | 177,514 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:07 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" |
99,601 | $0 | 99,601 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:06 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO |
268,924 | $0 | 268,924 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
99,601 | $0 | 424,816 (Direct) |
View |
| 2023-03-04 Exercise |
2023-03-07 4:05 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
68,028 | $0 | 424,816 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
99,601 | $0 | 507,925 (Direct) |
View |
| 2023-03-04 Exercise |
2023-03-07 4:04 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
77,421 | $0 | 507,925 (Direct) |
View |
| 2023-03-03 Option Award |
2023-03-07 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
249,003 | $0 | 536,470 (Direct) |
View |
| 2023-03-04 Exercise |
2023-03-07 4:03 pm |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
72,009 | $0 | 536,470 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:39 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer |
3,219 | $0 | 30,996 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:38 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
63,383 | $0 | 21,404 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:37 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shani Eli EVP,Global Marketing&Portfolio |
5,311 | $0 | 30,364 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:36 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
70,840 | $0 | 269,084 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:36 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
63,383 | $0 | 97,818 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:35 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Inbar Galia See "Remarks" |
4,828 | $0 | 25,023 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:34 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
67,112 | $0 | 131,014 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:33 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Dethlefs Sven EVP, North America Commercial |
59,655 | $0 | 182,727 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 07:33 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial |
70,840 | $0 | 90,369 (Direct) |
View |
| 2023-02-15 Option Award |
2023-02-17 07:03 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO |
484,966 | $0 | 484,966 (Direct) |
View |
| 2023-02-13 Exercise |
2023-02-15 07:20 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
6,629 | $0 | 22,635 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 07:06 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Stark David Matthew Exec. VP Chief Legal Officer |
44,953 | $0 | 44,953 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 07:05 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets |
50,242 | $0 | 50,242 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 07:04 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer |
44,953 | $0 | 44,953 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 07:03 am |
N/A N/A |
TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Drape Eric Executive VP Global Operations |
47,598 | $0 | 47,598 (Direct) |
View |